UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature medicine, ISSN 1078-8956, 01/2009, Volume 15, Issue 1, pp. 97 - 103
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | CD5 Antigens - genetics | Hyperlipidemias - genetics | Protein Binding - genetics | Atherosclerosis - genetics | Molecular Sequence Data | Atherosclerosis - etiology | Protein Multimerization - genetics | Female | Hyperlipidemias - complications | Platelet Factor 4 - genetics | Amino Acid Sequence | Atherosclerosis - pathology | Hyperlipidemias - metabolism | Mice, Inbred C57BL | Models, Molecular | Chemokines - genetics | Atherosclerosis - metabolism | Mice, Knockout | Aorta - pathology | Animals | Blood Platelets - metabolism | Apolipoproteins E - genetics | Hyperlipidemias - pathology | Chemokines - metabolism | Mice | Prevention | Blood platelets | Atherosclerosis | Physiological aspects | Research | Risk factors | Chemokines | Cardiovascular disease | Lipids | Diet | Rodents | Veins & arteries | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2014, Volume 237, Issue 1, pp. 140 - 145
Cardiovascular | Familial combined hyperlipidemia | Heterozygous familial hypercholesterolemia | Diabetes mellitus | Statins | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Blood Pressure | Hyperlipidemias - genetics | Life Style | Hyperlipidemia, Familial Combined - complications | Prospective Studies | Anthropometry | Humans | Middle Aged | Male | Incidence | Adult | Female | Hyperlipidemias - complications | Blood Glucose - chemistry | Hyperlipidemias - drug therapy | Risk Factors | Diabetes Mellitus - drug therapy | Proportional Hazards Models | Diabetes Complications - drug therapy | Hyperlipidemia, Familial Combined - genetics | Treatment Outcome | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Heterozygote | Hyperlipidemia, Familial Combined - drug therapy | Care and treatment | Hypercholesterolemia | Low density lipoproteins | Genetic aspects | Diabetes | Risk factors | Diabetes therapy | Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 06/2019, Volume 139, Issue 25, pp. e1082 - e1143
Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hyperlipidemias - blood | Risk Assessment | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Hyperlipidemias - drug therapy | Risk Factors | Treatment Outcome | Biomarkers - blood | Cardiology - standards | Anticholesteremic Agents - adverse effects | Consensus | Hyperlipidemias - diagnosis | Evidence-Based Medicine - standards | Hyperlipidemias - epidemiology | Anticholesteremic Agents - therapeutic use | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - diagnosis | Index Medicus | Abridged Index Medicus
Journal Article
Pancreas, ISSN 0885-3177, 2014, Volume 43, Issue 4, pp. 548 - 552
Clinical features | Acute pancreatitis | Hyperlipidemia | Hypertriglyceridemia | Incidence | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Recurrence | Residence Characteristics | Acute Disease | Hyperlipidemias - blood | Pancreatitis - therapy | Pancreatitis - epidemiology | Humans | Risk Factors | Treatment Outcome | Biomarkers - blood | China - epidemiology | Pancreatitis - mortality | Hyperlipidemias - diagnosis | Pancreatitis - diagnosis | Hyperlipidemias - epidemiology | Hyperlipidemias - mortality | Pancreatitis - blood | Time Factors | Hospitals, General | Retrospective Studies | Hyperlipidemias - therapy | Index Medicus
Journal Article
Ageing research reviews, ISSN 1568-1637, 2010, Volume 9, Issue 4, pp. 399 - 417
Neurology | Internal Medicine | Hypertension | Insulin resistance | Metabolic syndrome | Mild cognitive impairment | Alzheimer's disease | Leptin | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Cell Biology | Life Style | Hyperlipidemias - blood | Humans | Obesity, Abdominal - metabolism | Obesity, Abdominal - physiopathology | tau Proteins - metabolism | Metabolic Syndrome - metabolism | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - epidemiology | Hyperlipidemias - epidemiology | Obesity, Abdominal - epidemiology | Amyloid beta-Peptides - metabolism | Diabetes Mellitus, Type 2 - therapy | Metabolic Syndrome - physiopathology | Aged, 80 and over | Alzheimer Disease - epidemiology | Hypertension - epidemiology | Hypertension - therapy | Hyperlipidemias - physiopathology | Hyperlipidemias - therapy | Metabolic Syndrome - epidemiology | Biomarkers - metabolism | Effect Modifier, Epidemiologic | Alzheimer Disease - physiopathology | Hyperlipidemias - metabolism | Comorbidity | Risk Factors | Alzheimer Disease - therapy | Aging - psychology | Metabolic Syndrome - therapy | Obesity, Abdominal - therapy | Hypertension - physiopathology | Hypertension - metabolism | Cholesterol, HDL - standards | Animals | Diabetes Mellitus, Type 2 - physiopathology | Aging - physiology | Alzheimer Disease - metabolism | Cholesterol, HDL - blood | Aged | Mice | Population Dynamics | Index Medicus
Journal Article